beta blocker: affect asthma

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
affect asthma 1.00
be bad for asthma 0.95
make asthma worse 0.94
trigger asthma 0.92
worsen asthma 0.91
cause asthma attacks 0.90
exacerbate asthma 0.90
be contraindicated in asthma 0.84
be contraindicated with asthma 0.84
be contraindicated in patients with asthma 0.83

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.46
Similarity weight: 0.84
Evidence: 0.83
¬ Remarkable(beta blocker, affect asthma) ⋁
Evidence: 0.65
¬ Remarkable(atenolol, be contraindicated in asthma)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.87
Similarity weight: 0.84
Evidence: 0.52
Plausible(beta blocker, affect asthma) ⋁
Evidence: 0.65
Remarkable(atenolol, be contraindicated in asthma) ⋁
Evidence: 0.75
¬ Plausible(atenolol, be contraindicated in asthma)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.52
Plausible(beta blocker, affect asthma) ⋁
Evidence: 0.71
¬ Salient(beta blocker, affect asthma)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.95
Evidence: 0.83
Remarkable(beta blocker, affect asthma) ⋁
Evidence: 0.57
¬ Remarkable(beta blocker, be bad for asthma)
0.70
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.91
Evidence: 0.83
Remarkable(beta blocker, affect asthma) ⋁
Evidence: 0.60
¬ Remarkable(beta blocker, worsen asthma)
0.70
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.92
Evidence: 0.83
Remarkable(beta blocker, affect asthma) ⋁
Evidence: 0.64
¬ Remarkable(beta blocker, trigger asthma)
0.69
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.90
Evidence: 0.83
Remarkable(beta blocker, affect asthma) ⋁
Evidence: 0.59
¬ Remarkable(beta blocker, exacerbate asthma)
0.66
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.95
Evidence: 0.71
Salient(beta blocker, affect asthma) ⋁
Evidence: 0.66
¬ Salient(beta blocker, be bad for asthma)
...

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.71
Salient(beta blocker, affect asthma) ⋁
Evidence: 0.44
¬ Typical(beta blocker, affect asthma) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, affect asthma)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.52
Plausible(beta blocker, affect asthma) ⋁
Evidence: 0.44
¬ Typical(beta blocker, affect asthma)

Typicality and Rermarkability incompatibility between siblings

0.04
Rule weight: 0.14
Evidence weight: 0.35
Similarity weight: 0.84
Evidence: 0.83
¬ Remarkable(beta blocker, affect asthma) ⋁
Evidence: 0.79
¬ Typical(atenolol, be contraindicated in asthma)